A Study to Analyse the Immediate Effect of Dry Needling and Extra Corporeal Shock Wave Therapy on Hand Grip Strength
NCT ID: NCT04645758
Last Updated: 2020-12-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
27 participants
INTERVENTIONAL
2020-11-29
2020-11-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dry Needling Group or (DN)
Dry needling for 5 mins on the flexor group of muscles of dominant forearm.
Dry needling and Extra corporeal Shock wave therapy
5 mins of dry needling and 1250 pulses of shockwave therapy on dominant forearm muscles
Extra corporeal Shockwave therapy Group or (ESWT)
Delivering of Shock wave pulses of 1250 at the energy intensity of 0.58 mj/mm2 on the flexor group of muscles of dominant forearm
Dry needling and Extra corporeal Shock wave therapy
5 mins of dry needling and 1250 pulses of shockwave therapy on dominant forearm muscles
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dry needling and Extra corporeal Shock wave therapy
5 mins of dry needling and 1250 pulses of shockwave therapy on dominant forearm muscles
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Muscle power of 4+ on oxford manual muscle testing of forearm and wrist extrinsic and intrinsic muscles
* Full range of motion in all dominant upper extremity joints.
Exclusion Criteria
* Teno-synovitis of flexor tendons ,
* Dequervains synovitis,
* Left hand dominance.
21 Years
46 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Comprehensive Rehabilitation Centre, Medina, Saudi Arabia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rayan Mohammed Al Fadani
Head of the Department of Physical therapy and Rehabilitation.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rayan M Al-Fadani, BPT
Role: PRINCIPAL_INVESTIGATOR
Comprehensive rehabilitation centre, Medina Al Munawwarah, Saudi Arabia.
Abdullah M Al-Shenqiti, PhD,PT
Role: STUDY_DIRECTOR
Taibah University of Medical Rehabilitation Sciences
Tarek M El-Gohary, PhD,PT
Role: STUDY_CHAIR
Taibah University of Medical Rehabilitation Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Comprehensive Rehabilitation Centre
Madinah, , Saudi Arabia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Mohammed A Khan
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Rct001
Identifier Type: -
Identifier Source: org_study_id